Literature DB >> 31945379

The Development and Validation of Prostate Cancer-specific Physician-Hospital Networks.

Bruce L Jacobs1, Jonathan G Yabes2, Samia H Lopa3, Dwight E Heron4, Chung-Chou H Chang5, Justin E Bekelman6, Joel B Nelson3, Julie P W Bynum7, Amber E Barnato8, Jeremy M Kahn9.   

Abstract

OBJECTIVE: To develop prostate cancer-specific physician-hospital networks to define hospital-based units that more accurately group hospitals, providers, and the patients they serve.
METHODS: Using Surveillance, Epidemiology, and End Results-Medicare, we identified men diagnosed with localized prostate cancer between 2007 and 2011. We created physician-hospital networks by assigning each patient to a physician and each physician to a hospital based on treatment patterns. We assessed content validity by examining characteristics of hospitals anchoring the physician-hospital networks and of the patients associated with these hospitals.
RESULTS: We identified 42,963 patients associated with 344 physician-hospital networks. Networks anchored by a teaching hospital (compared to a nonteaching hospital) had higher median numbers of prostate cancer patients (117 [interquartile range {71-189} vs 82 {50-126}]) and treating physicians (7 [4-11] vs 4 [3-6]) (both P <0.001). On average, patients traveled farther to networks anchored by a teaching hospital (49 miles [standard deviation] [207] vs 41 [183]; P <.001). Hospitals known as high-volume centers for robotic prostatectomies, proton-beam therapy, and active surveillance had network rates for these procedures well above the mean. Hospitals known as safety net providers served higher proportions of minorities.
CONCLUSION: We empirically developed prostate-cancer specific physician-hospital networks that exhibit content validity and are relevant from a clinical and policy perspective. They have the potential to become targets for policy interventions focused on improving the delivery of prostate cancer care.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 31945379      PMCID: PMC7141943          DOI: 10.1016/j.urology.2019.11.049

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  21 in total

1.  Discharge patterns after radical prostatectomy in the United States of America.

Authors:  Quoc-Dien Trinh; Marco Bianchi; Maxine Sun; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Claudio Jeldres; Kevin Zorn; Paul Perrotte; Craig G Rogers; James O Peabody; Francesco Montorsi; Mani Menon; Pierre I Karakiewicz
Journal:  Urol Oncol       Date:  2011-11-18       Impact factor: 3.498

2.  Radiation therapy facilities in the United States.

Authors:  Leslie K Ballas; Elena B Elkin; Deborah Schrag; Bruce D Minsky; Peter B Bach
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-11-15       Impact factor: 7.038

3.  Understanding regional variation in Medicare expenditures for initial episodes of prostate cancer care.

Authors:  Shi-Yi Wang; Rong Wang; James B Yu; Xiaomei Ma; Xiao Xu; Simon P Kim; Pamela R Soulos; Avantika Saraf; Cary P Gross
Journal:  Med Care       Date:  2014-08       Impact factor: 2.983

4.  Use of advanced treatment technologies among men at low risk of dying from prostate cancer.

Authors:  Bruce L Jacobs; Yun Zhang; Florian R Schroeck; Ted A Skolarus; John T Wei; James E Montie; Scott M Gilbert; Seth A Strope; Rodney L Dunn; David C Miller; Brent K Hollenbeck
Journal:  JAMA       Date:  2013-06-26       Impact factor: 56.272

5.  Incidence of initial local therapy among men with lower-risk prostate cancer in the United States.

Authors:  David C Miller; Stephen B Gruber; Brent K Hollenbeck; James E Montie; John T Wei
Journal:  J Natl Cancer Inst       Date:  2006-08-16       Impact factor: 13.506

6.  Assigning ambulatory patients and their physicians to hospitals: a method for obtaining population-based provider performance measurements.

Authors:  Julie P W Bynum; Enrique Bernal-Delgado; Daniel Gottlieb; Elliott Fisher
Journal:  Health Serv Res       Date:  2007-02       Impact factor: 3.402

7.  Physician social networks and variation in prostate cancer treatment in three cities.

Authors:  Craig Evan Pollack; Gary Weissman; Justin Bekelman; Kaijun Liao; Katrina Armstrong
Journal:  Health Serv Res       Date:  2011-10-18       Impact factor: 3.402

8.  Linking patients to hospitals. Defining urban hospital service populations.

Authors:  N P Roos
Journal:  Med Care       Date:  1993-05       Impact factor: 2.983

9.  Where does oncology fit in the scheme of accountable care?

Authors:  Ronald Barkley
Journal:  J Oncol Pract       Date:  2012-03       Impact factor: 3.840

10.  Early effect of Medicare Shared Savings Program accountable care organization participation on prostate cancer care.

Authors:  Tudor Borza; Samuel R Kaufman; Phyllis Yan; Lindsey A Herrel; Amy N Luckenbaugh; David C Miller; Ted A Skolarus; Bruce L Jacobs; John M Hollingsworth; Edward C Norton; Vahakn B Shahinian; Brent K Hollenbeck
Journal:  Cancer       Date:  2017-10-20       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.